Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Music Therapy on Pain

This study has been completed.
Sponsor:
Collaborators:
Centre d'Evaluation et du Traitement de la Douleur CHU Saint-Eloi
Unité de Recherche Clinique et Epidémiologie (DIM) CHU Arnaud de Villeneuve
Centre Mémoire de Ressource et de Recherche équipe INSERM U888 CHU Montpellier
Information provided by:
Association de Musicothérapie Applications et Recherches Cliniques
ClinicalTrials.gov Identifier:
NCT01020032
First received: November 23, 2009
Last updated: November 24, 2009
Last verified: November 2009

November 23, 2009
November 24, 2009
September 2006
November 2008   (final data collection date for primary outcome measure)
Score on a Visual Analogical Scale (VAS) for actual pain [ Time Frame: Day 0, day 5, day 10, day 60 and day 90 ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01020032 on ClinicalTrials.gov Archive Site
  • Score on the Hospital Anxiety and Depression (HAD) Scale [ Time Frame: Day 0, day 5, day 10, day 60 and day 90 ] [ Designated as safety issue: No ]
  • Medicinal consumption [ Time Frame: Before hospitalization, day 0, day 5, day 10, day 60 and day 90 ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Effect of Music Therapy on Pain
Effect of Music Therapy on Chronic Pain in Hospitalized Patients in a Pain Center

The aim of study is to assess the effects of this new music therapy technique on pain treatment, anxiety and depression and on medicinal consumption.

The "U" technique is a music therapy method of recent use developed by taking into account recommendations of the scientific literature. The objective of the study is to evaluate this method on chronic painful patients presenting a lumbago, a fibromyalgia, an inflammatory or neurological pathology. During the hospitalization, the intervention group benefited from at least 2 daily sessions of music therapy between day 0 and day 10, and continued the musicotherapy at home until day 60. The evaluated criteria are pain, depression and anxiety and their evolution after 60 days of treatment (since the inclusion). The evaluation at day 90 allows to test the persistence of the effect of the music therapy 90 days later.

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Single Blind (Outcomes Assessor)
Primary Purpose: Treatment
Chronic Pain
Other: Individual receptive music therapy by "U sequence" method
During the hospitalization, the intervention group benefited from at least 2 daily sessions of music therapy between day 0 and day 10, and continued the musicotherapy at home until day 60.
Experimental: Music therapy
Individual receptive music therapy by "U sequence" method
Intervention: Other: Individual receptive music therapy by "U sequence" method

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
87
December 2008
November 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Have a pain for more than 6 months
  • Pain of neurological origin (fibromyalgia, algodystrophies), or skeletal musculous (back, sciatic nerve)
  • Speak and read French fluently
  • Wrote consent of patients
  • Benefit from the standard treatment : Intravenous treatment (tranquillizer, antidepressive) the first 5 days, 2 time by day (in the morning and evening), followed by the intermediary orally up to the exit (prescribed doses and at request)

Exclusion Criteria:

  • Time of hospitalization < 8 days
  • Reflex epilepsy history
  • Major insufficiency of auditory function
  • Patient with a strong possibility of not compliance to the protocol or of abandon in the course of study
  • Presence of an illness threatening vital forecast during period envisaged for the study
Both
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT01020032
AMARC 200801
No
GUETIN, AMARC
Association de Musicothérapie Applications et Recherches Cliniques
  • Centre d'Evaluation et du Traitement de la Douleur CHU Saint-Eloi
  • Unité de Recherche Clinique et Epidémiologie (DIM) CHU Arnaud de Villeneuve
  • Centre Mémoire de Ressource et de Recherche équipe INSERM U888 CHU Montpellier
Principal Investigator: Stéphane GUETIN, PhD Association de Musicothérapie Applications et Recherches Cliniques
Association de Musicothérapie Applications et Recherches Cliniques
November 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP